Antiplatelet Therapy In Patients With Atrial Fibrillation
Edoxaban in combination with a P2Y12 inhibitor is noninferior to standard triple therapy for preventing bleeding in patients with atrial fibrillation after coronary stenting. The late breaking results of the ENTRUST-AF PCI trial are present in a Hot Line Session today at ESC Congress 2019 together with the World Congress of Cardiology and published in…